Dexamethasone treatment at birth enhances neonatal growth in swine.
The objective of the present study was to determine if dexamethasone (Dex; a potent synthetic glucocorticoid) treatment at birth would alter postnatal growth in neonatal pigs. Forty crossbred pigs were injected i.m. with either sterile saline (Cont; n = 10 males and 10 females) or Dex (1 mg/kg; n = 10 males and 10 females) within 1 hr of birth. All pigs remained with their respective dams until 18 d of age. Body weights were recorded weekly and on d 18. On d 17, all pigs were nonsurgically fitted with an indwelling jugular catheter and placed back with the sows. On d 18, all pigs were placed in individual pens for serial blood collection. Birth weights (1.53 +/-.04 kg) did not differ between birth treatments or sex classes (P > 0.70 and 0.89, respectively). A time by treatment effect was detected (P < 0.007) for body weight such that those pigs which received Dex at birth had the greatest body weights during the 18-d period. Average daily gain was increased (P < 0.017) by 12.2% in those pigs which received Dex at birth (.286 +/-.007) as compared to the Cont pigs (.255 +/-.01 kg/d). Serum concentration of IGF-1 was influenced by both treatment (P < 0.0001) and sex class (P < 0.013). In the male pigs, Dex increased (P = 0.0041) serum concentration of IGF-1 by 47% as compared to Cont male pigs, whereas in the females, Dex increased (P < 0.011) serum concentration of IGF-1 by 34% as compared to Cont female pigs. Dex treatment reduced (P < 0.002) serum IGF-2 by 12.8%. Serum concentration of IGFBP-3 was influenced by both birth treatment (P < 0.007) and sex class (P < 0.002) such that Dex treatment increased serum IGFBP-3, and higher concentrations of IGFBP-3 were observed in boars as compared to gilts. These data suggest that the early neonatal period may be an opportune time to alter physiological factors which influence growth in swine.